AMINOSYN 3.5% M
LOE Approachingamino acids; magnesium acetate; phosphoric acid; potassium acetate; sodium chloride
NDAINJECTIONINJECTABLE
Approved
May 1976
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 16h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
AMINOSYN 3.5% M is a sterile, nonpyrogenic solution of essential and nonessential amino acids with electrolytes (magnesium acetate, phosphoric acid, potassium acetate, sodium chloride) for intravenous injection. It is indicated for parenteral nutrition support in patients requiring amino acid supplementation when oral intake is inadequate or impossible. The formulation provides nitrogen and essential nutrients to maintain protein synthesis and metabolic function in hospitalized and critically ill patients.
LOE Approaching
Product is approaching loss of exclusivity with moderate competitive pressure (30% intensity), indicating potential team restructuring and shift toward cost management and hospital channel strategy.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on AMINOSYN 3.5% M offers limited career advancement potential given its mature lifecycle, zero linked job postings, and absence of patent exclusivity. Roles focus on hospital relationship management, cost competitiveness, and supply chain reliability rather than innovation or growth.
Account Manager (Hospital/IDN)Supply Chain Specialist
Worked on AMINOSYN 3.5% M at ICU Medical? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.